January 15th, 2025 – We are thrilled to announce a pivotal achievement in Pharmatech AI’s history: The construction of our state-of-the-art MDIP Lab Grow Module was completed on schedule in January 2025. This 200 m² cutting-edge research facility combines vertical cannabis cultivation with AI-driven analytics, marking a major leap forward in our mission to revolutionize drug research through data-driven precision.
A Laboratory of the Future – Designed for AI-Powered Research
The MDIP Lab Grow is the heart of our proprietary cannabinoid research, generating over 50,000 data points per cultivation cycle—from chemical profiles (THC, CBD, terpenes) to biological assays. With fully automated controls (IoT sensors, adaptive LED lighting, CO₂ circulation) and sustainable resource use (40% reduction in water and fertilizer consumption), it sets new standards for efficiency and scientific rigor.
Core Features of the Module:
- Multi-tier vertical farming with stackable units for maximum space efficiency.
- Real-time monitoring via sensors (temperature, humidity, light spectra).
- Precision analytics using HPLC and GC-MS to quantify 23 cannabinoids and terpenes.
- AI integration: Data flows directly into our AI-MDIP model (Graph Neural Networks) to predict drug interactions.
Why This Lab is a Gamechanger
Traditional drug research suffers from fragmented data and high costs. Our closed-loop system of cultivation, extraction, and AI analysis solves these challenges:
- Data sovereignty: Full control from seed to analyzed flower—no reliance on public datasets.
- Scalability: Each cycle expands our knowledge base with 15,000+ data points for sharper AI predictions.
- Sustainability: Energy-efficient systems reduce environmental impact—aligned with our 55 MWp solar park in Mecklenburg-Vorpommern.
Next Steps: From Validation to Therapy Development
With commissioning now complete, we begin:
- Biological validation: In vitro and in vivo tests to verify AI predictions (e.g., pain relief from THC-CBD combinations).
- Data integration: Training the AI-MDIP model with cannabis-specific interaction data (target: 50,000 entries).
- Partnerships: Collaborations with pharma companies to develop novel cannabinoid therapies.
Gratitude to Our Team and Partners
This milestone was achieved through the collaboration of biotechnologists, data scientists, and agricultural engineers, supported by strategic partners in agritech and AI development. Special thanks to our Lead Cannabis Lab Analyst Miguel Martinez Bermudez and the entire cultivation team for their pioneering work.
Outlook: The Future Starts Now
The MDIP Lab Grow is just the beginning. Plans are already underway to double capacity for researching rare cannabinoid-terpene synergies. Additionally, the data will fuel our B2B SaaS platform (launch Q1 2026) and decentralized Data Marketplace, both key pillars of our business model.
Stay tuned: More updates on our research findings coming soon!